Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine for Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer
NCT07889115Phase 2Not yet recruiting
- Sponsor
- Al-Azhar University
- Start
- Dec 2026
- Primary completion
- Dec 2027
01
Overview
A Phase 2 trial of amantadine in peripheral neuropathy, sponsored by Al-Azhar University. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
amantadine
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT07889115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07889115.